(11-465) Medication Use Evaluation of L-Ornithine L-Aspartate (LOLA) Supplementation for the Treatment of Hepatic Encephalopathy
Wednesday, December 10, 2025
12:30 PM - 1:30 PM
Location: Bayside A, Level 1
Residency Program: University of Rochester Medical Center/Strong Memorial Hospital Residency Program Type: PGY1 (Pharmacy) Residency Program Location: New York
Co-Author(s): Jennifer Cooley, Travis Dick, Lauren Gashlin